Solventum (SOLV) Other Non-Current Assets (2023 - 2026)
Solventum's (SOLV) quarterly Other Non-Current Assets came in at $848.0 million in Q1 2026, down 59.73% YoY from $2.1 billion in Q1 2025, and up 4.18% on a QoQ basis from $814.0 million in Q4 2025.
Solventum (SOLV) Other Non-Current Assets (2023 - 2026) Analysis & Trends
Solventum (SOLV) has 4 years of Other Non-Current Assets data on file, last reported at $848.0 million in Q1 2026.
- Quarterly Other Non-Current Assets fell 59.73% year-over-year to $848.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $848.0 million (down 59.73% YoY) and the FY2025 annual result came in at $814.0 million, up 22.41% from the prior year.
- Other Non-Current Assets improved to $848.0 million in Q1 2026, from $814.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $2.1 billion in Q1 2025 to a low of $168.0 million in Q2 2025.
- A 4-year average of $751.7 million and a median of $624.0 million in 2024 frame the typical range for Other Non-Current Assets.
- The widest YoY moves for Other Non-Current Assets: up 261.23% in 2025, down 66.86% in 2025.
- Tracing SOLV's Other Non-Current Assets over 4 years: stood at $530.0 million in 2023, then gained by 25.47% to $665.0 million in 2024, then gained by 22.41% to $814.0 million in 2025, then climbed by 4.18% to $848.0 million in 2026.
- The last three Other Non-Current Assets figures came in at $848.0 million (Q1 2026), $814.0 million (Q4 2025), and $747.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | 452.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 904.00 Mn |
| Mar 31, 2026 | 848.00 Mn |
| Dec 31, 2025 | 814.00 Mn |
| Sep 30, 2025 | 747.00 Mn |
| Jun 30, 2025 | 168.00 Mn |
| Mar 31, 2025 | 2.11 Bn |
| Dec 31, 2024 | 665.00 Mn |
| Sep 30, 2024 | 549.00 Mn |
| Jun 30, 2024 | 507.00 Mn |
| Mar 31, 2024 | 583.00 Mn |
| Dec 31, 2023 | 530.00 Mn |